{
  "id": "5c630666e842deac6700000c",
  "type": "factoid",
  "question": "Which microRNA is the mediator of the obesity phenotype of patients carrying 1p21.3 microdeletions?",
  "ideal_answer": "MIR137 is the mediator of the obesity phenotype of patients carrying 1p21.3 microdeletions.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/27822311",
    "http://www.ncbi.nlm.nih.gov/pubmed/22003227"
  ],
  "snippets": [
    {
      "text": "MIR137 is the mediator of the obesity phenotype of patients carrying 1p21.3 microdeletions.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27822311",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "CONCLUSIONS\nThis study suggests that MIR137 is the mediator of the obesity phenotype of patients carrying 1p21.3 microdeletions.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27822311",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "CASE PRESENTATION\nWe describe a 10-year-old boy with syndromic obesity who carries a novel 1p21.3\u00a0deletion overlapping the critical region with the MIR137 gene only.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27822311",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "CONCLUSIONS\nThis study showed that dosage effects of MIR137 are associated with 1p21.3 microdeletions and may therefore contribute to the ID phenotype in patients with deletions harbouring this miRNA.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22003227",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "CONCLUSIONS This study suggests that MIR137 is the mediator of the obesity phenotype of patients carrying 1p21.3 microdeletions.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27822311",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "CASE PRESENTATION We describe a 10-year-old boy with syndromic obesity who carries a novel 1p21.3\u00a0deletion overlapping the critical region with the MIR137 gene only.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27822311",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "CONCLUSIONS This study showed that dosage effects of MIR137 are associated with 1p21.3 microdeletions and may therefore contribute to the ID phenotype in patients with deletions harbouring this miRNA.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22003227",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Therefore, this study investigated the possible involvement of MIR137 in the 1p21.3-deletion phenotype.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22003227",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "<AbstractText Label=\"CONCLUSIONS\" NlmCategory=\"CONCLUSIONS\">This study showed that dosage effects of MIR137 are associated with 1p21.3 microdeletions and may therefore contribute to the ID phenotype in patients with deletions harbouring this miRNA. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22003227",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "<AbstractText Label=\"CASE PRESENTATION\" NlmCategory=\"METHODS\">We describe a 10-year-old boy with syndromic obesity who carries a novel 1p21.3\u00a0deletion overlapping the critical region with the <i>MIR137</i> gene only. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27822311",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "<AbstractText Label=\"CONCLUSIONS\" NlmCategory=\"CONCLUSIONS\">This study suggests that <i>MIR137</i> is the mediator of the obesity phenotype of patients carrying 1p21.3 microdeletions.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27822311",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "<i>MIR137</i> is the key gene mediator of the syndromic obesity phenotype of patients with 1p21.3 microdeletions.<AbstractText Label=\"BACKGROUND\" NlmCategory=\"BACKGROUND\">Deletions in the long arm of chromosome 1 have been described in patients with a phenotype consisting primarily of obesity, intellectual disability and autism-spectrum disorder. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27822311",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Therefore, this study investigated the possible involvement of MIR137 in the 1p21.3-deletion phenotype.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22003227",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The study also demonstrated significant enrichment of miR-137 at the synapses of cortical and hippocampal neurons, suggesting a role of miR-137 in regulating local synaptic protein synthesis machinery.<br><b>CONCLUSIONS</b>: This study showed that dosage effects of MIR137 are associated with 1p21.3 microdeletions and may therefore contribute to the ID phenotype in patients with deletions harbouring this miRNA.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22003227",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "MIR137 is the key gene mediator of the syndromic obesity phenotype of patients with 1p21.3 microdeletions.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27822311",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "This study suggests that MIR137 is the mediator of the obesity phenotype of patients carrying 1p21.3 microdeletions.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27822311",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "We describe a 10-year-old boy with syndromic obesity who carries a novel 1p21.3\u00a0deletion overlapping the critical region with the MIR137 gene only.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27822311",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "This study showed that dosage effects of MIR137 are associated with 1p21.3 microdeletions and may therefore contribute to the ID phenotype in patients with deletions harbouring this miRNA.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22003227",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Chromosome 1p21.3 microdeletions comprising DPYD and MIR137 are associated with intellectual disability.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22003227",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Therefore, this study investigated the possible involvement of MIR137 in the 1p21.3-deletion phenotype.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22003227",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "MIR137"
}